Marvin J. Fritzler

Active 1978–2024

153
Papers
24,197
Citations
81
h-index
152
i10-index

Citations

Citations per year for Marvin J. Fritzler1980: 5 citations1981: 7 citations1982: 22 citations1983: 23 citations1984: 25 citations1985: 29 citations1986: 24 citations1987: 34 citations1988: 32 citations1989: 22 citations1990: 29 citations1991: 28 citations1992: 25 citations1993: 18 citations1994: 23 citations1995: 20 citations1996: 24 citations1997: 25 citations1998: 30 citations1999: 42 citations2000: 41 citations2001: 42 citations2002: 40 citations2003: 53 citations2004: 55 citations2005: 93 citations2006: 133 citations2007: 187 citations2008: 167 citations2009: 182 citations2010: 198 citations2011: 132 citations2012: 198 citations2013: 132 citations2014: 152 citations2015: 144 citations2016: 131 citations2017: 139 citations2018: 158 citations2019: 568 citations2020: 632 citations2021: 645 citations2022: 636 citations2023: 382 citations2024: 666 citations2025: 266 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,049 citing papers, 24.4% of this breakdownUnited Kingdom: 599 citing papers, 7.1% of this breakdownGermany: 542 citing papers, 6.4% of this breakdownItaly: 513 citing papers, 6.1% of this breakdownChina: 477 citing papers, 5.7% of this breakdownCanada: 476 citing papers, 5.7% of this breakdownFrance: 423 citing papers, 5% of this breakdownJapan: 360 citing papers, 4.3% of this breakdownNetherlands: 256 citing papers, 3% of this breakdownSwitzerland: 218 citing papers, 2.6% of this breakdownSpain: 194 citing papers, 2.3% of this breakdownAustralia: 181 citing papers, 2.2% of this breakdown
0%24.4%Other 25.2%

Fields

  • Medicine62.2%
  • Biochemistry, Genetics and Molecular Biology29.3%
  • Immunology and Microbiology4.8%
  • Agricultural and Biological Sciences1.6%
  • Neuroscience0.7%
  • Environmental Science0.5%
  • Other0.9%

Topics

  • Systemic Sclerosis and Related Diseases7.9%
  • Systemic Lupus Erythematosus Research7.3%
  • RNA Research and Splicing5.4%
  • Inflammatory Myopathies and Dermatomyositis5.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.6%
  • RNA modifications and cancer3.4%
  • Other67.3%

Coauthors

All papers

Open in search
  1. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara K. Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa Fernández, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Thomas Dörner, Sindhu R. Johnson - Annals of the Rheumatic Diseases 2019 cited by 2,515

  2. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard T. Meehan, Arthur C. Theodore, Robert W. Simms, Suncica Volkov, Dean E. Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A. Molitor, Kristin B. Highland, Charles A. Read, Marvin J. Fritzler, Grace Hyun J. Kim, Chi‐Hong Tseng, Robert M. Elashoff - The Lancet Respiratory Medicine 2016 cited by 1,062

  3. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling

    Authors: , , , , , , , , , - The Journal of Cell Biology 2005 cited by 1,480

  4. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 271

  5. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guillermo Ruiz‐Irastorza, Sam Lim, Murat İnanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Jill P. Buyon, David Sontag, Karen H. Costenbader - Annals of the Rheumatic Diseases 2023 cited by 81

  6. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective

    Authors: , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 360

  7. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicole Fabien, Renato Alberto Sinico, Pier Luigi Meroni, Yehuda Shoenfeld, JW Cohen Tervaert, D Hamann, RHWM Derksen, H Hooijkaas, I Klasen, P Limburg, R Smeenk, P van Daele, Kerstin Elvin, Charlotte Dahle, Thomas Skogh, Jaakko Antonen, Anna-Maija Haapala, Marja Hietarinta, Teija Häkkinen, Arno Hänninen, Sakari Jokiranta, Anna Karjalainen, Aino Laatikainen, Marjatta Leirisalo-Repo, Riitta Luosujärvi, Aaro Miettinen, Jari Siuro, Sune Sved, Tamara Tuuminen, Timo Walle, Fátima Coelho, Maria José Santos, Mónica Bogas, João P Ramos, João Faro-Viana, Nils Olivier Olsson, Georges Chyderiotis, Bach-Nga, Vincent Aubert, Clemens Dahinden, Eric Dayer, Françoise Mascart, Jean-Paul Tomasi, Martine Vercammen, Patrick Verschueren, Fréderic Houssiau, Bernard Lauwerys, Filip De Keyser, Walter Fierz, Ingmar Heijnen, Franco Keller, Gerhard Müllner, Stephan Regenass, Pascale Roux-Lombard, Urs Wirthmüller, Boris Gilburde, Rachel Levi, Daphna Lipinsky, Mira Barak, Abu-Shakra Mahmud, Ruth Fishel, Mina Foguel, Kivity Shay, Elena Csernok, Bernhard Schlüter, Bettina Becker, Rudolf Mierau, Torsten Witte, Wolfram Seidel, Ingrid Frank and 25 more - Annals of the Rheumatic Diseases 2013 cited by 612

  8. 2020 international consensus on ANCA testing beyond systemic vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 cited by 154

  9. N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis

    Authors: , , , , , , , - Frontiers in Immunology 2022 cited by 51

  10. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014–2015

    Authors: , , , , , , , , , , , , - Frontiers in Immunology 2015 cited by 377

  11. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

    Authors: , , , , , , , , , , - Arthritis & Rheumatism 2008 cited by 602

  12. Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value

    Authors: , , , , , , , , , , , - Autoimmunity Reviews 2023 cited by 32

  13. Range of antinuclear antibodies in “healthy” individuals

    Authors: , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 1997 cited by 873

  14. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies

    Authors: , , , , , , , , , , - Autoimmunity Reviews 2021 cited by 87

  15. Autoantibodies in systemic sclerosis

    Authors: , , , - Autoimmunity Reviews 2012 cited by 248

  16. Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

    Authors: , , , , , , , , , , , - Arthritis Research & Therapy 2010 cited by 179

  17. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiara Tani, Sara K. Tedeschi, Zahi Touma, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Karen H. Costenbader, Sindhu R. Johnson - Annals of the Rheumatic Diseases 2021 cited by 67

  18. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis

    Authors: , , , , , , , , , , , , , , , , - Neurology 2021 cited by 67

  19. Expression of a constitutively active humanSTINGmutant in hematopoietic cells produces anIfnar1-dependent vasculopathy in mice

    Authors: , , , , , , , , , , , - Life Science Alliance 2019 cited by 33

  20. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus

    Authors: , , , , - Autoimmunity Reviews 2020 cited by 97

  21. How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative

    Authors: , , , , , , , , , , , , , , , - Immunologic Research 2021 cited by 75

  22. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: A comprehensive review

    Authors: , , - Autoimmunity Reviews 2014 cited by 292

  23. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

    Authors: , , , , , , - Arthritis Research & Therapy 2012 cited by 147

  24. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hélène Couture, Ira N. Targoff, Marvin J. Fritzler, Jean‐Luc Senécal - Arthritis Research & Therapy 2020 cited by 69